Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65051 - 65075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	FIGNL1	63979	upregulated	resveratrol results in increased expression of FIGNL1 mRNA	7p12.2	A21103
Resveratrol	Investigational	FIS1	51024	upregulated	resveratrol results in increased expression of FIS1 mRNA	7q22.1	A23940
Resveratrol	Investigational	FLOT1	10211	upregulated	resveratrol results in increased expression of FLOT1 mRNA	6p21.33	A22498
Resveratrol	Investigational	FLT1	2321	downregulated	resveratrol results in decreased expression of FLT1 mRNA	13q12.3	A23941
Resveratrol	Investigational	FMNL2	114793	downregulated	resveratrol results in decreased expression of FMNL2 mRNA	2q23.3	A21103
Resveratrol	Investigational	FN1	2335	downregulated	resveratrol results in decreased expression of FN1 mRNA	2q35	A23876
Resveratrol	Investigational	FN1	2335	downregulated	resveratrol results in decreased expression of FN1 mRNA alternative form	2q35	A23850
Resveratrol	Investigational	FOS	2353	upregulated	resveratrol metabolite results in increased expression of FOS mRNA	14q24.3	A20106
Resveratrol	Investigational	FOS	2353	upregulated	resveratrol results in increased expression of FOS mRNA	14q24.3	A23899 A23942 A23903 A23845
Resveratrol	Investigational	FOXA2	3170	downregulated	resveratrol results in decreased expression of FOXA2 mRNA	20p11.21	A23876
Resveratrol	Investigational	FOXA2	3170	upregulated	resveratrol results in increased expression of FOXA2 mRNA	20p11.21	A23876
Resveratrol	Investigational	FOXD1	2297	upregulated	resveratrol results in increased expression of FOXD1 mRNA	5q13.2	A22289
Resveratrol	Investigational	FOXE1	2304	upregulated	resveratrol results in increased expression of FOXE1 mRNA	9q22.33	A23943
Resveratrol	Investigational	FOXM1	2305	upregulated	resveratrol results in increased expression of FOXM1 mRNA	12p13.33	A21103
Resveratrol	Investigational	FOXN3	1112	downregulated	resveratrol results in decreased expression of FOXN3 mRNA	14q31.3-q32.11	A23847
Resveratrol	Investigational	FOXO3	2309	upregulated	resveratrol results in increased expression of FOXO3 mRNA	6q21	A23887
Resveratrol	Investigational	FST	10468	upregulated	resveratrol results in increased expression of FST mRNA	5q11.2	A23908 A23852
Resveratrol	Investigational	FTCD	10841	upregulated	resveratrol results in increased expression of FTCD mRNA	21q22.3	A23845
Resveratrol	Investigational	FTH1	2495	upregulated	resveratrol results in increased expression of FTH1 mRNA	11q12.3	A23944
Resveratrol	Investigational	FXN	2395	upregulated	resveratrol results in increased expression of FXN mRNA	9q21.11	A21394
Resveratrol	Investigational	G0S2	50486	upregulated	resveratrol results in increased expression of G0S2 mRNA	1q32.2	A23908
Resveratrol	Investigational	G2E3	55632	upregulated	resveratrol results in increased expression of G2E3 mRNA	14q12	A21103
Resveratrol	Investigational	GABARAP	11337	upregulated	resveratrol results in increased expression of GABARAP mRNA	17p13.1	A23856
Resveratrol	Investigational	GADD45A	1647	upregulated	resveratrol results in increased expression of GADD45A mRNA	1p31.3	A23859 A23902 A23872
Resveratrol	Investigational	GADD45G	10912	upregulated	resveratrol results in increased expression of GADD45G mRNA	9q22.2	A23577

Displaying entries 65051 - 65075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability